Hoon Ryu, PhD

Adjunct Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Hoon Ryu earned his doctoral degree from Chonbuk National University, South Korea. He completed a postdoctoral research fellowship and was appointed Instructor of Neurology at Beth Israel Deaconess Medical Center and Harvard Medical School in 1999. He joined the Chobanian and Avedisian School of Medicine’s Department of Neurology in 2004 as an Assistant Professor. Now he is an Associate Professor and an investigator with the Boston University Alzheimer’s Disease Center and VA Boston Healthcare System. He is a director of the laboratory for Neuronal Gene Regulation and Epigenetics. He works on the identification of biomarkers, the determination of molecular genetic, epigenetic mechanisms, and the development of therapeutics using cell culture systems and animal models of neurodegeneration. He has published over 70 original reports.

Research Interests:

Epigenetic changes encompass an array of molecular modifications including DNA methylation and changes to the chromatin packaging of DNA by post-translational histone modifications. The structure, dynamics, and chemical properties of chromatin almost completely determines how, when, and which genes are turned on and off. Chromatin remodeling and transcription regulation are tightly controlled under physiological conditions. Deregulation of chromatin remodeling is linked to the pathogenesis of neurodegenerative disorders but the mechanism is elusive. In order to identify how genomes are deregulated by heterochromatin, Dr. Ryu is performing ChIP genome-wide sequencing combined with RNA-sequencing followed by platform integration analysis. He has found that altered chromatin plasticity is closely linked to the pathogenesis of Huntington’s disease via an expression of ESET (ERG-associated protein with a SET domain), a histone H3K9-specific methyltransferase. Currently, he is conducting research about mechanisms of ESET gene induction and neuronal heterochromatin condensation in Alzheimer’s disease.

Publications

  • Published 5/1/2026

    Verkhratsky A, Lee CJ, Chun H, Göritz C, Harkany T, Lee JH, Lee S, Lindskog M, Koh W, Mulder J, Nam MH, Ottersen OP, Pekna M, Pekny M, Pekowska A, Ryu H, Sohn CH, Tretiakov EO, Untiet V, Viney TJ, Youn W, Yi C, Zorec R, Yun M, Cheong E, Nordberg A. Author Correction: Curing the brain: in search for new astrocyte-specific therapies. Exp Mol Med. 2026 May; 58(5):1688-1689. PMID: 42115334.

    Read at: PubMed

  • Published 4/24/2026

    Verkhratsky A, Lee CJ, Chun H, Göritz C, Harkany T, Lee JH, Lee S, Lindskog M, Koh W, Mulder J, Nam MH, Ottersen OP, Pekna M, Pekny M, Pekowska A, Ryu H, Sohn CH, Tretiakov EO, Untiet V, Viney TJ, Youn W, Yi C, Zorec R, Yun M, Cheong E, Nordberg A. Curing the brain: in search for new astrocyte-specific therapies. Exp Mol Med. 2026 Apr; 58(4):1086-1127. PMID: 42032208.

    Read at: PubMed

  • Published 4/14/2026

    Lim Y, Jeon B, Park SA, Lee J, Choi SW, Jeong CW, Ryu HG, Lee HY, Yang HL. Large language model-augmented offline reinforcement learning framework for sepsis management in critical care. NPJ Digit Med. 2026 Apr 14; 9(1). PMID: 41975229.

    Read at: PubMed

  • Published 4/9/2026

    Darsono WHW, Hwang Y, Valencia E, Gunawan LT, Hyeon SJ, Ryu H, Stein TD, Chang MY, Wulansari N, Lee SH. Dysregulation of astrocytic DNAJC6 contributes to sporadic Parkinson's disease pathogenesis. J Clin Invest. 2026 Jun 01; 136(11). PMID: 41955024.

    Read at: PubMed

  • Published 2/5/2026

    Kim HY, Kim S, Akaydin AN, Kim S, Hyeon SJ, Lee J, Ryu H. The rise of astrocytes: are they guardians or troublemakers of the brain disorder? Exp Mol Med. 2026 Mar; 58(2):301-318. PMID: 41639424.

    Read at: PubMed

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University

Websites

Education

  • Chonbuk National University, PhD
  • Chonbuk National University, MS
  • Chonbuk National University, BS